BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 22, 2011
View Archived Issues
Gene therapy shows promise in phase I Leber's congenital amaurosis study
Read More
EMA to begin review of Pfizer's tofacitinib MAA for rheumatoid arthritis
Read More
Exodos Life Science completes pre-IND meeting for ELS-115
Read More
Novel biomarker for ankylosing spondylitis identified
Read More
Phase II data reported for LY-2439821 in patients with rheumatoid arthritis
Read More
Data from phase III trials support benefits of tofacitinib in rheumatoid arthritis
Read More
Maximum tolerated dose of LDE-225 determined in patients with solid tumors
Read More
Novel tyrosine-protein kinase SYK inhibitor evaluated in arthritis model
Read More
Merck & Co. synthesizes novel M1 receptor positive allosteric modulators
Read More
New mGlu2 receptor agonists described by Merck & Co.
Read More
Merck & Co. presents novel lysosomal Pro-X carboxypeptidase inhibitors
Read More
PharmacoFore discloses new tapentadol prodrugs for pain
Read More
Novel modulators of skeletal muscle contractility patented by Cytokinetics
Read More
FDA approves Erwinaze for acute lymphoblastic leukemia
Read More
Convergence Pharmaceuticals begins phase I study of CNV-2197944
Read More
CHMP recommends variation to marketing terms for Nevanac
Read More
Phosphagenics begins pivotal TPM/oxycodone patch trials
Read More
Merrimack Pharmaceuticals begins enrollment in MM-121/erlotinib combination trial
Read More
TONIX Pharmaceuticals obtains FDA clearance to begin TNX-102 trial
Read More
Cabozantinib trial begins in hormone receptor-positive breast cancer
Read More
Companies collaborate on DNA-based therapy for pulmonary arterial hypertension
Read More
Gilead Sciences signs definitive agreement to acquire Pharmasset
Read More
GW Pharmaceuticals files application seeking approval of Sativex in more European countries
Read More
FDA approves Abbott's supplemental Chagas' disease assay
Read More
FDA accepts for review NDA for aripiprazole depot formulation in schizophrenia
Read More
